{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:01:18Z","timestamp":1780300878873,"version":"3.54.0"},"reference-count":0,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Renier Brentjens, MD, PhD, a pioneer of chimeric antigen receptor (CAR) T-cell therapy, speaks about his early work in the field, the current limitations of CAR T cells, and how researchers might advance the technology in the coming years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-nw2026-0032","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T18:32:17Z","timestamp":1775845937000},"page":"OF1-OF1","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Q&amp;A: Renier Brentjens on Obstacles and Opportunities in CAR T-cell Therapy"],"prefix":"10.1158","volume":"16","member":"1086","published-online":{"date-parts":[[2026,4,10]]},"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/doi\/10.1158\/2159-8290.CD-NW2026-0032\/782743\/Q-amp-A-Renier-Brentjens-on-Obstacles-and","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/6\/OF1\/785521\/Q-amp-A-Renier-Brentjens-on-Obstacles-and","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/6\/OF1\/785521\/Q-amp-A-Renier-Brentjens-on-Obstacles-and","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:15:49Z","timestamp":1780298149000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/6\/OF1\/785521\/Q-amp-A-Renier-Brentjens-on-Obstacles-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,4,10]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-nw2026-0032","relation":{},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]}}}